Trial Profile
Effects of Sorafenib on Intrahepatic Circulations in Patients with Advanced Hepatocullar Carcinoma: A Prospective Cohort Study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2011
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics
- 12 Oct 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 19 Sep 2011 Planned End Date added to 1 Dec 2011 as reported by University Hospital Medical Information Network - Japan.
- 03 May 2011 New trial record